Effect of Two Different Doses of Neostigmine on the Gastric Residual Volume and Aspiration in Critically Ill Patients
NCT06687187 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3
Last updated 2024-11-13
Summary
A study comparing the effect of two doses of neostigmine on the gastric residual volume in critically ill patients on enteral feeding.
Conditions
- Gastric Reflux
Interventions
- DRUG
-
Neostigmine
two groups (Group I, n= 41) and (Group II, n= 43) received varying doses of neostigmine (1 mg and 2 mg respectively
Sponsors & Collaborators
-
Zulekha Hospitals
lead OTHER
Principal Investigators
-
abdalla e hassan, lecturer · lecturer
Eligibility
- Min Age
- 20 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-01
- Primary Completion
- 2024-04-01
- Completion
- 2024-05-01
Countries
- Egypt
Study Locations
More Related Trials
-
Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects
NCT02232308 ·Status: COMPLETED ·Phase: PHASE1
-
Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy
NCT07104214 ·Status: RECRUITING
-
Evaluating Patients With Abnormal Levels of Gastric Acid
NCT00001240 ·Status: COMPLETED
-
Evaluation of Gastric Insufflation Measured by Ultrasound of the Antral Surface During Optiflow Preoxygenation
NCT04206111 ·Status: UNKNOWN
-
Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms
NCT04661215 ·Status: RECRUITING
-
The Effect of Early Enteral Nutrition Feeding Process Assisted by Gastrointestinal Ultrasonography
NCT05379582 ·Status: COMPLETED ·Phase: NA
-
The Effects of Z-338 in Subjects With and Without Functional Dyspepsia
NCT00298194 ·Status: COMPLETED ·Phase: PHASE2
-
An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia
NCT00358410 ·Status: COMPLETED ·Phase: PHASE2
-
Endoscopic Gastric Reduction of Gastric Mucosa in Obesity
NCT06231251 ·Status: RECRUITING ·Phase: NA
-
Role of Octreotide in Non Variceal Bleeding
NCT06062719 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleeding
NCT02695732 ·Status: UNKNOWN ·Phase: PHASE4
-
Establishing Gastric Sonography in a Swiss Teaching Hospital
NCT04738006 ·Status: COMPLETED
-
Gastric Ultrasound for Preoperative Assessment of Gastric Content in Diabetic Patients
NCT04181814 ·Status: COMPLETED
-
Intermittent Oro-esophageal Tube Feeding on Cerebral Small Vessel Disease Patients With Dysphagia
NCT06179550 ·Status: TERMINATED ·Phase: NA
-
The Use of Domperidone for Gastroparesis
NCT01378884 ·Status: WITHDRAWN ·Phase: PHASE3
-
Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders
NCT05905016 ·Status: RECRUITING
-
Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias
NCT06306963 ·Status: RECRUITING
-
Effect of Oral Enteral Nutrition on Cerebral Small Vessel Disease
NCT06303999 ·Status: COMPLETED ·Phase: NA
-
Washed Microbiota Transplantation Combined with Enteral Nutrition for Gastroptosis
NCT06837194 ·Status: RECRUITING
-
IS There a Correlation Between Sypmtoms of Gastroparesis and the Duration of Video Caspule Retention in the Stomach
NCT01858220 ·Status: UNKNOWN
-
Intravenous NTG to Preserve Gastric Microcirculation During Gastric Tube Reconstruction
NCT00335010 ·Status: COMPLETED ·Phase: NA
-
Body Surface Gastric Mapping Vs Gastric Emptying Scintigraphy on Clinical Management in Gastroparesis
NCT06411574 ·Status: RECRUITING ·Phase: NA
-
Patient Understanding (Cognitive Debriefing) of a Daily Diary of Gastroparesis Symptoms
NCT01316484 ·Status: COMPLETED
-
Gastric Emptying: in Vivo Studies in Healthy Volunteers
NCT02994472 ·Status: UNKNOWN ·Phase: NA
-
Gastric Motor Function Measurement in Dyspepsia and Normal Subjects
NCT00296582 ·Status: COMPLETED ·Phase: NA